Correction to: Detection and Monitoring of Interstitial Lung Disease in Patients with Systemic Sclerosis
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1534-6307
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Correction to: Detection and Monitoring of Interstitial Lung Disease in Patients with Systemic Sclerosis ; volume:24 ; number:10 ; day:25 ; month:8 ; year:2022 ; pages:321 ; date:10.2022
Current rheumatology reports ; 24, Heft 10 (25.8.2022), 321, 10.2022
- Urheber
-
Khanna, Surabhi Agarwal
Nance, John W.
Suliman, Sally A.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s11926-022-01085-3
- URN
-
urn:nbn:de:101:1-2022113021122351529988
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:20 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Khanna, Surabhi Agarwal
- Nance, John W.
- Suliman, Sally A.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Pathogenesis of interstitial lung disease in systemic sclerosis
Interstitial lung disease associated with systemic sclerosis (SSc-ILD)
Biomarkers in Systemic Sclerosis Associated Interstitial Lung Disease (SSc-ILD)
Systemic sclerosis-associated interstitial lung disease: How to manage in 2024?
Serum metabolites as biomarkers in systemic sclerosis-associated interstitial lung disease
Expert consensus on the management of systemic sclerosis-associated interstitial lung disease
Macrophages as determinants and regulators of systemic sclerosis-related interstitial lung disease
Usefulness of monitoring mycophenolic acid exposure in systemic sclerosis-related interstitial lung disease: a retrospective cohort study
CD19 + CD21lo/neg cells are increased in systemic sclerosis-associated interstitial lung disease
Extracellular vesicles and interstitial lung disease in systemic sclerosis: State of the art!
Incidence Rate and Prevalence of Systemic Sclerosis and Systemic Sclerosis-Associated Interstitial Lung Disease in Japan: Analysis Using Japanese Claims Databases
Circulating cytokine levels in systemic sclerosis related interstitial lung disease and idiopathic pulmonary fibrosis
Pathogenesis of interstitial lung disease in systemic sclerosis
Interstitial lung disease associated with systemic sclerosis (SSc-ILD)
Biomarkers in Systemic Sclerosis Associated Interstitial Lung Disease (SSc-ILD)
Systemic sclerosis-associated interstitial lung disease: How to manage in 2024?
Serum metabolites as biomarkers in systemic sclerosis-associated interstitial lung disease
Expert consensus on the management of systemic sclerosis-associated interstitial lung disease
Macrophages as determinants and regulators of systemic sclerosis-related interstitial lung disease
Usefulness of monitoring mycophenolic acid exposure in systemic sclerosis-related interstitial lung disease: a retrospective cohort study
CD19 + CD21lo/neg cells are increased in systemic sclerosis-associated interstitial lung disease
Extracellular vesicles and interstitial lung disease in systemic sclerosis: State of the art!
Incidence Rate and Prevalence of Systemic Sclerosis and Systemic Sclerosis-Associated Interstitial Lung Disease in Japan: Analysis Using Japanese Claims Databases
Circulating cytokine levels in systemic sclerosis related interstitial lung disease and idiopathic pulmonary fibrosis
Pathogenesis of interstitial lung disease in systemic sclerosis
Interstitial lung disease associated with systemic sclerosis (SSc-ILD)
Biomarkers in Systemic Sclerosis Associated Interstitial Lung Disease (SSc-ILD)
Systemic sclerosis-associated interstitial lung disease: How to manage in 2024?
Serum metabolites as biomarkers in systemic sclerosis-associated interstitial lung disease
Expert consensus on the management of systemic sclerosis-associated interstitial lung disease
Macrophages as determinants and regulators of systemic sclerosis-related interstitial lung disease
Usefulness of monitoring mycophenolic acid exposure in systemic sclerosis-related interstitial lung disease: a retrospective cohort study
CD19 + CD21lo/neg cells are increased in systemic sclerosis-associated interstitial lung disease
Extracellular vesicles and interstitial lung disease in systemic sclerosis: State of the art!
Incidence Rate and Prevalence of Systemic Sclerosis and Systemic Sclerosis-Associated Interstitial Lung Disease in Japan: Analysis Using Japanese Claims Databases